Cargando…
Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors
Several studies report the key role of the vascular endothelial growth factor (VEGF) signaling on angiogenesis and on tumor growth. This has led to the development of a number of VEGF-targeted agents to treat cancer patients by disrupting the tumor blood vessel supply. Of them, bevacizumab, an FDA-a...
Autores principales: | de Aguiar, Rodrigo Barbosa, de Moraes, Jane Zveiter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530399/ https://www.ncbi.nlm.nih.gov/pubmed/31156623 http://dx.doi.org/10.3389/fimmu.2019.01023 |
Ejemplares similares
-
Anti‐bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor‐binding response, impairing tumor outgrowth
por: Sanches, Jéssica de Souza, et al.
Publicado: (2016) -
Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response
por: Silva, Tábata Almeida, et al.
Publicado: (2022) -
Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer
por: Yuan, Xiao, et al.
Publicado: (2021) -
Immunological Regulation of Vascular Inflammation During Cancer Metastasis
por: McDowell, Sheri A. C., et al.
Publicado: (2019) -
Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody
por: de Aguiar, Rodrigo Barbosa, et al.
Publicado: (2021)